Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.

You can find text and video tutorials here that explain how to use our system.

FUJIFILM Diosynth Biotechnologies Denmark ApS

CVR number: 26060702
Biotek Allé 1, 3400 Hillerød
tel: 77416070

Credit rating

Company information

Official name
FUJIFILM Diosynth Biotechnologies Denmark ApS
Established
2001
Company form
Private limited company
Industry
  • Expand more icon21Manufacture of basic pharmaceutical products and pharmaceutical preparations

About the company

FUJIFILM Diosynth Biotechnologies Denmark ApS (CVR number: 26060702) is a company from HILLERØD. The company reported a net sales of 3450.9 mDKK in 2022, demonstrating a growth of 12.4 % compared to the previous year. The operating profit percentage was at 19.1 % (EBIT: 659.4 mDKK), while net earnings were 470.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was 7.1 %, which can be considered decent but Return on Equity (ROE) was 10.9 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 34.4 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. FUJIFILM Diosynth Biotechnologies Denmark ApS's liquidity measured by quick ratio was 0.3 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.

Financial information

See financials

Net sales (mDKK)

EBIT (mDKK)

Profitability

Solidity

Key figures (mDKK)

See financials
20182019202020212022
Volume
Net sales1 417.172 039.472 727.433 068.983 450.90
Gross profit214.1965.12494.44561.261 004.86
EBIT317.58- 237.00218.00287.80659.43
Net earnings253.50- 176.32103.55213.46470.32
Shareholders equity total3 938.183 761.873 865.424 078.884 549.20
Balance sheet total (assets)4 540.605 495.145 848.438 455.6213 683.66
Net debt-80.021 094.50478.332 212.446 106.58
Profitability
EBIT-%22.4 %-11.6 %8.0 %9.4 %19.1 %
ROA7.3 %-4.2 %4.3 %4.7 %7.1 %
ROE6.7 %-4.6 %2.7 %5.4 %10.9 %
ROI7.7 %-4.5 %4.9 %5.9 %9.0 %
Economic value added (EVA)65.08- 373.78-16.5048.38312.81
Solvency
Equity ratio86.7 %68.5 %69.6 %49.9 %34.4 %
Gearing2.5 %30.4 %21.0 %55.3 %137.3 %
Relative net indebtedness %13.2 %73.6 %48.1 %131.9 %249.2 %
Liquidity
Quick ratio2.10.60.90.70.3
Current ratio2.10.91.00.90.4
Cash and cash equivalents178.9449.46331.9145.03140.26
Capital use efficiency
Trade debtors turnover (days)75.445.426.933.4
Net working capital %28.5 %-7.6 %2.8 %-9.5 %-154.5 %
Credit risk
Credit ratingAABBAAAAA

Variable visualization

ROA:7.14%
Rating: 49/100
-20%
0%
4%
11%
24%
60%
Equity ratio:34.4%
Rating: 29/100
-1%
21%
50%
81%
99%
100%

Roles

Companies in the same industry

Build time: 2024-07-12T11:31:01.896Z

Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.